R-Tech Ueno

August 16, 2010	R-Tech Ueno Submits a Request for Arbitration against Takeda Pharmaceutical
August 12, 2010	Please see "Quarterly report for the 1st quarter of fiscal year ending March 31, 2011 (Japanese Version)" which is shown on our Japanese website.
August 12, 2010	Please see "Announcement of business result for the 1st quarter of fiscal year ending March 31, 2011 (Japanese Version)" which is shown on our Japanese website.
July 22, 2010	Announcement of Change in Storage Condition for Rescula® Eye Drops 0.12%
July 15, 2010	Notification related to the Completion of the Phase II Clinical Study of the Ophthalmic Solution UF-021 (product name Ocuseva(TM)) on Retinitis Pigmentosa (2)

R-Tech Ueno's originally developed Rescula® Eye Drops is a glaucoma/ocular hypertension treatment drug that was the first in the world to utilize Prostone.

Head Office: NBF Hibiya Bldg., 10F, 1-1-7 Uchisaiwaicho, Chiyoda-ku, Tokyo 100-0011, Japan